---
document_datetime: 2025-12-02 05:25:33
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/medicines/human/EPAR/imprida.html
document_name: imprida.html
version: success
processing_time: 0.1247417
conversion_datetime: 2025-12-25 03:03:05.841172
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
# Imprida

[RSS](/en/individual-human-medicine.xml/66893)

##### Withdrawn

This medicine's authorisation has been withdrawn

amlodipine / valsartan Medicine Human Withdrawn

Page contents

## Page contents

- [Overview](#overview)
- [Product information](#product-info)
- [Product details](#product-details)
- [Authorisation details](#authorisation-details)
- [Assessment history](#assessment-history)
- [News on Imprida](#news-on)
- [More information on Imprida](#more-information-on-imprida-1471)

- Application under evaluation
- CHMP opinion
- European Commission decision

## Overview

On 3 April 2017, the European Commission withdrew the marketing authorisation for Imprida (amlodipine / valsartan) in the European Union (EU). The withdrawal was at the request of the marketing authorisation holder, Novartis Europharm Ltd, which notified the European Commission of its decision to permanently discontinue the marketing of the product for commercial reasons.

Imprida was granted marketing authorisation in the EU on 17 January 2007 for treatment of essential hypertension. It was then granted unlimited validity in 2011. Imprida is a medicine that contains two active substances, amlodipine and valsartan. There are other medicinal products marketed in the EU that contain this combination of substances as well as products containing amlodipine or valsartan alone.

The European Public Assessment Report (EPAR) for Imprida is updated accordingly to reflect the fact that the marketing authorisation is no longer valid

Imprida : EPAR - Summary for the public

English (EN) (541.81 KB - PDF)

**First published:** 05/05/2009

**Last updated:** 11/05/2017

[View](/en/documents/overview/imprida-epar-summary-public_en.pdf)

[Other languages (22)](#file-language-dropdown-743)

български (BG) (633.91 KB - PDF)

**First published:**

05/05/2009

**Last updated:**

11/05/2017

[View](/bg/documents/overview/imprida-epar-summary-public_bg.pdf)

español (ES) (566.39 KB - PDF)

**First published:**

05/05/2009

**Last updated:**

11/05/2017

[View](/es/documents/overview/imprida-epar-summary-public_es.pdf)

čeština (CS) (610.61 KB - PDF)

**First published:**

05/05/2009

**Last updated:**

11/05/2017

[View](/cs/documents/overview/imprida-epar-summary-public_cs.pdf)

dansk (DA) (543.07 KB - PDF)

**First published:**

05/05/2009

**Last updated:**

11/05/2017

[View](/da/documents/overview/imprida-epar-summary-public_da.pdf)

Deutsch (DE) (545.51 KB - PDF)

**First published:**

05/05/2009

**Last updated:**

11/05/2017

[View](/de/documents/overview/imprida-epar-summary-public_de.pdf)

eesti keel (ET) (540.73 KB - PDF)

**First published:**

05/05/2009

**Last updated:**

11/05/2017

[View](/et/documents/overview/imprida-epar-summary-public_et.pdf)

ελληνικά (EL) (630.27 KB - PDF)

**First published:**

05/05/2009

**Last updated:**

11/05/2017

[View](/el/documents/overview/imprida-epar-summary-public_el.pdf)

français (FR) (545.46 KB - PDF)

**First published:**

05/05/2009

**Last updated:**

11/05/2017

[View](/fr/documents/overview/imprida-epar-summary-public_fr.pdf)

hrvatski (HR) (565.16 KB - PDF)

**First published:**

05/05/2009

**Last updated:**

11/05/2017

[View](/hr/documents/overview/imprida-epar-summary-public_hr.pdf)

italiano (IT) (543.05 KB - PDF)

**First published:**

05/05/2009

**Last updated:**

11/05/2017

[View](/it/documents/overview/imprida-epar-summary-public_it.pdf)

latviešu valoda (LV) (608.63 KB - PDF)

**First published:**

05/05/2009

**Last updated:**

11/05/2017

[View](/lv/documents/overview/imprida-epar-summary-public_lv.pdf)

lietuvių kalba (LT) (568.19 KB - PDF)

**First published:**

05/05/2009

**Last updated:**

11/05/2017

[View](/lt/documents/overview/imprida-epar-summary-public_lt.pdf)

magyar (HU) (602.95 KB - PDF)

**First published:**

05/05/2009

**Last updated:**

11/05/2017

[View](/hu/documents/overview/imprida-epar-summary-public_hu.pdf)

Malti (MT) (611.76 KB - PDF)

**First published:**

05/05/2009

**Last updated:**

11/05/2017

[View](/mt/documents/overview/imprida-epar-summary-public_mt.pdf)

Nederlands (NL) (542.41 KB - PDF)

**First published:**

05/05/2009

**Last updated:**

11/05/2017

[View](/nl/documents/overview/imprida-epar-summary-public_nl.pdf)

polski (PL) (609.65 KB - PDF)

**First published:**

05/05/2009

**Last updated:**

11/05/2017

[View](/pl/documents/overview/imprida-epar-summary-public_pl.pdf)

português (PT) (543.89 KB - PDF)

**First published:**

05/05/2009

**Last updated:**

11/05/2017

[View](/pt/documents/overview/imprida-epar-summary-public_pt.pdf)

română (RO) (569.23 KB - PDF)

**First published:**

05/05/2009

**Last updated:**

11/05/2017

[View](/ro/documents/overview/imprida-epar-summary-public_ro.pdf)

slovenčina (SK) (608.48 KB - PDF)

**First published:**

05/05/2009

**Last updated:**

11/05/2017

[View](/sk/documents/overview/imprida-epar-summary-public_sk.pdf)

slovenščina (SL) (596.71 KB - PDF)

**First published:**

05/05/2009

**Last updated:**

11/05/2017

[View](/sl/documents/overview/imprida-epar-summary-public_sl.pdf)

Suomi (FI) (542.15 KB - PDF)

**First published:**

05/05/2009

**Last updated:**

11/05/2017

[View](/fi/documents/overview/imprida-epar-summary-public_fi.pdf)

svenska (SV) (543.48 KB - PDF)

**First published:**

05/05/2009

**Last updated:**

11/05/2017

[View](/sv/documents/overview/imprida-epar-summary-public_sv.pdf)

## Product information

Imprida : EPAR - Product Information

English (EN) (1.28 MB - PDF)

**First published:** 05/05/2009

**Last updated:** 11/05/2017

[View](/en/documents/product-information/imprida-epar-product-information_en.pdf)

[Other languages (24)](#file-language-dropdown-684)

български (BG) (1.75 MB - PDF)

**First published:**

05/05/2009

**Last updated:**

11/05/2017

[View](/bg/documents/product-information/imprida-epar-product-information_bg.pdf)

español (ES) (1.38 MB - PDF)

**First published:**

05/05/2009

**Last updated:**

11/05/2017

[View](/es/documents/product-information/imprida-epar-product-information_es.pdf)

čeština (CS) (3.34 MB - PDF)

**First published:**

05/05/2009

**Last updated:**

11/05/2017

[View](/cs/documents/product-information/imprida-epar-product-information_cs.pdf)

dansk (DA) (1.36 MB - PDF)

**First published:**

05/05/2009

**Last updated:**

11/05/2017

[View](/da/documents/product-information/imprida-epar-product-information_da.pdf)

Deutsch (DE) (1.32 MB - PDF)

**First published:**

05/05/2009

**Last updated:**

11/05/2017

[View](/de/documents/product-information/imprida-epar-product-information_de.pdf)

eesti keel (ET) (1.26 MB - PDF)

**First published:**

05/05/2009

**Last updated:**

11/05/2017

[View](/et/documents/product-information/imprida-epar-product-information_et.pdf)

ελληνικά (EL) (1.69 MB - PDF)

**First published:**

05/05/2009

**Last updated:**

11/05/2017

[View](/el/documents/product-information/imprida-epar-product-information_el.pdf)

français (FR) (1.76 MB - PDF)

**First published:**

05/05/2009

**Last updated:**

11/05/2017

[View](/fr/documents/product-information/imprida-epar-product-information_fr.pdf)

hrvatski (HR) (1.41 MB - PDF)

**First published:**

05/05/2009

**Last updated:**

11/05/2017

[View](/hr/documents/product-information/imprida-epar-product-information_hr.pdf)

íslenska (IS) (1.92 MB - PDF)

**First published:**

05/05/2009

**Last updated:**

11/05/2017

[View](/is/documents/product-information/imprida-epar-product-information_is.pdf)

italiano (IT) (1.31 MB - PDF)

**First published:**

05/05/2009

**Last updated:**

11/05/2017

[View](/it/documents/product-information/imprida-epar-product-information_it.pdf)

latviešu valoda (LV) (1.66 MB - PDF)

**First published:**

05/05/2009

**Last updated:**

11/05/2017

[View](/lv/documents/product-information/imprida-epar-product-information_lv.pdf)

lietuvių kalba (LT) (1.44 MB - PDF)

**First published:**

05/05/2009

**Last updated:**

11/05/2017

[View](/lt/documents/product-information/imprida-epar-product-information_lt.pdf)

magyar (HU) (1.65 MB - PDF)

**First published:**

05/05/2009

**Last updated:**

11/05/2017

[View](/hu/documents/product-information/imprida-epar-product-information_hu.pdf)

Malti (MT) (1.59 MB - PDF)

**First published:**

05/05/2009

**Last updated:**

11/05/2017

[View](/mt/documents/product-information/imprida-epar-product-information_mt.pdf)

Nederlands (NL) (1.34 MB - PDF)

**First published:**

05/05/2009

**Last updated:**

11/05/2017

[View](/nl/documents/product-information/imprida-epar-product-information_nl.pdf)

norsk (NO) (1.31 MB - PDF)

**First published:**

05/05/2009

**Last updated:**

11/05/2017

[View](/no/documents/product-information/imprida-epar-product-information_no.pdf)

polski (PL) (1.68 MB - PDF)

**First published:**

05/05/2009

**Last updated:**

11/05/2017

[View](/pl/documents/product-information/imprida-epar-product-information_pl.pdf)

português (PT) (1.9 MB - PDF)

**First published:**

05/05/2009

**Last updated:**

11/05/2017

[View](/pt/documents/product-information/imprida-epar-product-information_pt.pdf)

română (RO) (1.43 MB - PDF)

**First published:**

05/05/2009

**Last updated:**

11/05/2017

[View](/ro/documents/product-information/imprida-epar-product-information_ro.pdf)

slovenčina (SK) (1.59 MB - PDF)

**First published:**

05/05/2009

**Last updated:**

11/05/2017

[View](/sk/documents/product-information/imprida-epar-product-information_sk.pdf)

slovenščina (SL) (1.51 MB - PDF)

**First published:**

05/05/2009

**Last updated:**

11/05/2017

[View](/sl/documents/product-information/imprida-epar-product-information_sl.pdf)

Suomi (FI) (1.54 MB - PDF)

**First published:**

05/05/2009

**Last updated:**

11/05/2017

[View](/fi/documents/product-information/imprida-epar-product-information_fi.pdf)

svenska (SV) (1.3 MB - PDF)

**First published:**

05/05/2009

**Last updated:**

11/05/2017

[View](/sv/documents/product-information/imprida-epar-product-information_sv.pdf)

**Latest procedure affecting product information:** WS/0709 03/04/2017

icon globe

<!-- image -->

This medicine's product information is available in all **official EU languages** . Select 'available languages' to access the language you need.

Product information documents contain:

- summary of product characteristics (annex I);
- manufacturing authorisation holder responsible for batch release (annex IIA);
- conditions of the marketing authorisation (annex IIB);
- labelling (annex IIIA);
- package leaflet (annex IIIB).

Imprida : EPAR - All Authorised presentations

English (EN) (599.25 KB - PDF)

**First published:** 20/05/2008

**Last updated:** 11/05/2017

[View](/en/documents/all-authorised-presentations/imprida-epar-all-authorised-presentations_en.pdf)

[Other languages (21)](#file-language-dropdown-730)

български (BG) (736.89 KB - PDF)

**First published:**

20/05/2008

**Last updated:**

11/05/2017

[View](/bg/documents/all-authorised-presentations/imprida-epar-all-authorised-presentations_bg.pdf)

español (ES) (600.94 KB - PDF)

**First published:**

20/05/2008

**Last updated:**

11/05/2017

[View](/es/documents/all-authorised-presentations/imprida-epar-all-authorised-presentations_es.pdf)

čeština (CS) (669.79 KB - PDF)

**First published:**

20/05/2008

**Last updated:**

11/05/2017

[View](/cs/documents/all-authorised-presentations/imprida-epar-all-authorised-presentations_cs.pdf)

dansk (DA) (599.89 KB - PDF)

**First published:**

20/05/2008

**Last updated:**

11/05/2017

[View](/da/documents/all-authorised-presentations/imprida-epar-all-authorised-presentations_da.pdf)

Deutsch (DE) (600.18 KB - PDF)

**First published:**

20/05/2008

**Last updated:**

11/05/2017

[View](/de/documents/all-authorised-presentations/imprida-epar-all-authorised-presentations_de.pdf)

eesti keel (ET) (608.27 KB - PDF)

**First published:**

20/05/2008

**Last updated:**

11/05/2017

[View](/et/documents/all-authorised-presentations/imprida-epar-all-authorised-presentations_et.pdf)

ελληνικά (EL) (735.82 KB - PDF)

**First published:**

20/05/2008

**Last updated:**

11/05/2017

[View](/el/documents/all-authorised-presentations/imprida-epar-all-authorised-presentations_el.pdf)

français (FR) (601.94 KB - PDF)

**First published:**

20/05/2008

**Last updated:**

11/05/2017

[View](/fr/documents/all-authorised-presentations/imprida-epar-all-authorised-presentations_fr.pdf)

italiano (IT) (604.25 KB - PDF)

**First published:**

20/05/2008

**Last updated:**

11/05/2017

[View](/it/documents/all-authorised-presentations/imprida-epar-all-authorised-presentations_it.pdf)

latviešu valoda (LV) (713.8 KB - PDF)

**First published:**

20/05/2008

**Last updated:**

11/05/2017

[View](/lv/documents/all-authorised-presentations/imprida-epar-all-authorised-presentations_lv.pdf)

lietuvių kalba (LT) (689.38 KB - PDF)

**First published:**

20/05/2008

**Last updated:**

11/05/2017

[View](/lt/documents/all-authorised-presentations/imprida-epar-all-authorised-presentations_lt.pdf)

magyar (HU) (719.36 KB - PDF)

**First published:**

20/05/2008

**Last updated:**

11/05/2017

[View](/hu/documents/all-authorised-presentations/imprida-epar-all-authorised-presentations_hu.pdf)

Malti (MT) (712.01 KB - PDF)

**First published:**

20/05/2008

**Last updated:**

11/05/2017

[View](/mt/documents/all-authorised-presentations/imprida-epar-all-authorised-presentations_mt.pdf)

Nederlands (NL) (600.11 KB - PDF)

**First published:**

20/05/2008

**Last updated:**

11/05/2017

[View](/nl/documents/all-authorised-presentations/imprida-epar-all-authorised-presentations_nl.pdf)

polski (PL) (665.55 KB - PDF)

**First published:**

20/05/2008

**Last updated:**

11/05/2017

[View](/pl/documents/all-authorised-presentations/imprida-epar-all-authorised-presentations_pl.pdf)

português (PT) (599.84 KB - PDF)

**First published:**

20/05/2008

**Last updated:**

11/05/2017

[View](/pt/documents/all-authorised-presentations/imprida-epar-all-authorised-presentations_pt.pdf)

română (RO) (682.92 KB - PDF)

**First published:**

20/05/2008

**Last updated:**

11/05/2017

[View](/ro/documents/all-authorised-presentations/imprida-epar-all-authorised-presentations_ro.pdf)

slovenčina (SK) (664.18 KB - PDF)

**First published:**

20/05/2008

**Last updated:**

11/05/2017

[View](/sk/documents/all-authorised-presentations/imprida-epar-all-authorised-presentations_sk.pdf)

slovenščina (SL) (625.43 KB - PDF)

**First published:**

20/05/2008

**Last updated:**

11/05/2017

[View](/sl/documents/all-authorised-presentations/imprida-epar-all-authorised-presentations_sl.pdf)

Suomi (FI) (605.01 KB - PDF)

**First published:**

20/05/2008

**Last updated:**

11/05/2017

[View](/fi/documents/all-authorised-presentations/imprida-epar-all-authorised-presentations_fi.pdf)

svenska (SV) (143.2 KB - PDF)

**First published:**

20/05/2008

**Last updated:**

11/05/2017

[View](/sv/documents/all-authorised-presentations/imprida-epar-all-authorised-presentations_sv.pdf)

## Product details

Name of medicine Imprida Active substance

- valsartan
- amlodipine (as amlodipine besilate)

International non-proprietary name (INN) or common name

- amlodipine
- valsartan

Therapeutic area (MeSH) Hypertension Anatomical therapeutic chemical (ATC) code C09DB01

### Pharmacotherapeutic group

Agents acting on the renin-angiotensin system

### Therapeutic indication

Treatment of essential hypertension.

Imprida is indicated in patients whose blood pressure is not adequately controlled on amlodipine or valsartan monotherapy.

## Authorisation details

EMA product number EMEA/H/C/000775 Marketing authorisation holder

Novartis Europharm Ltd

Frimley Business Park

Marketing authorisation issued 17/01/2007 Withdrawal of marketing authorisation 03/04/2017 Revision 20

## Assessment history

Expand section

Collapse section

## Changes since initial authorisation of medicine

Imprida : EPAR - Procedural steps taken and scientific information after authorisation

English (EN) (897.08 KB - PDF)

**First published:** 05/05/2009

**Last updated:** 11/05/2017

[View](/en/documents/procedural-steps-after/imprida-epar-procedural-steps-taken-and-scientific-information-after-authorisation_en.pdf)

Imprida-H-C-775-A31-0069 : EPAR - Scientific conclusions, grounds for variation to the terms of the marketing authorisations and detailed explanation of the scientific grounds for the differences from the PRAC recommenda...

English (EN) (527.93 KB - PDF)

**First published:** 30/09/2014

**Last updated:** 11/05/2017

[View](/en/documents/scientific-conclusion/imprida-h-c-775-a31-0069-epar-scientific-conclusions-grounds-variation-terms-marketing-authorisations-and-detailed-explanation-scientific-grounds-differences-prac-recommenda_en.pdf)

[Other languages (22)](#file-language-dropdown-126)

български (BG) (683.53 KB - PDF)

**First published:**

30/09/2014

**Last updated:**

11/05/2017

[View](/bg/documents/scientific-conclusion/imprida-h-c-775-a31-0069-epar-scientific-conclusions-grounds-variation-terms-marketing-authorisations-and-detailed-explanation-scientific-grounds-differences-prac-recommenda_bg.pdf)

español (ES) (532.05 KB - PDF)

**First published:**

30/09/2014

**Last updated:**

11/05/2017

[View](/es/documents/scientific-conclusion/imprida-h-c-775-a31-0069-epar-scientific-conclusions-grounds-variation-terms-marketing-authorisations-and-detailed-explanation-scientific-grounds-differences-prac-recommenda_es.pdf)

čeština (CS) (630.74 KB - PDF)

**First published:**

30/09/2014

**Last updated:**

11/05/2017

[View](/cs/documents/scientific-conclusion/imprida-h-c-775-a31-0069-epar-scientific-conclusions-grounds-variation-terms-marketing-authorisations-and-detailed-explanation-scientific-grounds-differences-prac-recommenda_cs.pdf)

dansk (DA) (528.78 KB - PDF)

**First published:**

30/09/2014

**Last updated:**

11/05/2017

[View](/da/documents/scientific-conclusion/imprida-h-c-775-a31-0069-epar-scientific-conclusions-grounds-variation-terms-marketing-authorisations-and-detailed-explanation-scientific-grounds-differences-prac-recommenda_da.pdf)

Deutsch (DE) (539.46 KB - PDF)

**First published:**

30/09/2014

**Last updated:**

11/05/2017

[View](/de/documents/scientific-conclusion/imprida-h-c-775-a31-0069-epar-scientific-conclusions-grounds-variation-terms-marketing-authorisations-and-detailed-explanation-scientific-grounds-differences-prac-recommenda_de.pdf)

eesti keel (ET) (530.67 KB - PDF)

**First published:**

30/09/2014

**Last updated:**

11/05/2017

[View](/et/documents/scientific-conclusion/imprida-h-c-775-a31-0069-epar-scientific-conclusions-grounds-variation-terms-marketing-authorisations-and-detailed-explanation-scientific-grounds-differences-prac-recommenda_et.pdf)

ελληνικά (EL) (692.49 KB - PDF)

**First published:**

30/09/2014

**Last updated:**

11/05/2017

[View](/el/documents/scientific-conclusion/imprida-h-c-775-a31-0069-epar-scientific-conclusions-grounds-variation-terms-marketing-authorisations-and-detailed-explanation-scientific-grounds-differences-prac-recommenda_el.pdf)

français (FR) (535.83 KB - PDF)

**First published:**

30/09/2014

**Last updated:**

11/05/2017

[View](/fr/documents/scientific-conclusion/imprida-h-c-775-a31-0069-epar-scientific-conclusions-grounds-variation-terms-marketing-authorisations-and-detailed-explanation-scientific-grounds-differences-prac-recommenda_fr.pdf)

hrvatski (HR) (567.49 KB - PDF)

**First published:**

30/09/2014

**Last updated:**

11/05/2017

[View](/hr/documents/scientific-conclusion/imprida-h-c-775-a31-0069-epar-scientific-conclusions-grounds-variation-terms-marketing-authorisations-and-detailed-explanation-scientific-grounds-differences-prac-recommenda_hr.pdf)

italiano (IT) (532.35 KB - PDF)

**First published:**

30/09/2014

**Last updated:**

11/05/2017

[View](/it/documents/scientific-conclusion/imprida-h-c-775-a31-0069-epar-scientific-conclusions-grounds-variation-terms-marketing-authorisations-and-detailed-explanation-scientific-grounds-differences-prac-recommenda_it.pdf)

latviešu valoda (LV) (631.93 KB - PDF)

**First published:**

30/09/2014

**Last updated:**

11/05/2017

[View](/lv/documents/scientific-conclusion/imprida-h-c-775-a31-0069-epar-scientific-conclusions-grounds-variation-terms-marketing-authorisations-and-detailed-explanation-scientific-grounds-differences-prac-recommenda_lv.pdf)

lietuvių kalba (LT) (568.45 KB - PDF)

**First published:**

30/09/2014

**Last updated:**

11/05/2017

[View](/lt/documents/scientific-conclusion/imprida-h-c-775-a31-0069-epar-scientific-conclusions-grounds-variation-terms-marketing-authorisations-and-detailed-explanation-scientific-grounds-differences-prac-recommenda_lt.pdf)

magyar (HU) (613.31 KB - PDF)

**First published:**

30/09/2014

**Last updated:**

11/05/2017

[View](/hu/documents/scientific-conclusion/imprida-h-c-775-a31-0069-epar-scientific-conclusions-grounds-variation-terms-marketing-authorisations-and-detailed-explanation-scientific-grounds-differences-prac-recommenda_hu.pdf)

Malti (MT) (634.18 KB - PDF)

**First published:**

30/09/2014

**Last updated:**

11/05/2017

[View](/mt/documents/scientific-conclusion/imprida-h-c-775-a31-0069-epar-scientific-conclusions-grounds-variation-terms-marketing-authorisations-and-detailed-explanation-scientific-grounds-differences-prac-recommenda_mt.pdf)

Nederlands (NL) (531.92 KB - PDF)

**First published:**

30/09/2014

**Last updated:**

11/05/2017

[View](/nl/documents/scientific-conclusion/imprida-h-c-775-a31-0069-epar-scientific-conclusions-grounds-variation-terms-marketing-authorisations-and-detailed-explanation-scientific-grounds-differences-prac-recommenda_nl.pdf)

polski (PL) (629.43 KB - PDF)

**First published:**

30/09/2014

**Last updated:**

11/05/2017

[View](/pl/documents/scientific-conclusion/imprida-h-c-775-a31-0069-epar-scientific-conclusions-grounds-variation-terms-marketing-authorisations-and-detailed-explanation-scientific-grounds-differences-prac-recommenda_pl.pdf)

português (PT) (530.2 KB - PDF)

**First published:**

30/09/2014

**Last updated:**

11/05/2017

[View](/pt/documents/scientific-conclusion/imprida-h-c-775-a31-0069-epar-scientific-conclusions-grounds-variation-terms-marketing-authorisations-and-detailed-explanation-scientific-grounds-differences-prac-recommenda_pt.pdf)

română (RO) (581.27 KB - PDF)

**First published:**

30/09/2014

**Last updated:**

11/05/2017

[View](/ro/documents/scientific-conclusion/imprida-h-c-775-a31-0069-epar-scientific-conclusions-grounds-variation-terms-marketing-authorisations-and-detailed-explanation-scientific-grounds-differences-prac-recommenda_ro.pdf)

slovenčina (SK) (629.27 KB - PDF)

**First published:**

30/09/2014

**Last updated:**

11/05/2017

[View](/sk/documents/scientific-conclusion/imprida-h-c-775-a31-0069-epar-scientific-conclusions-grounds-variation-terms-marketing-authorisations-and-detailed-explanation-scientific-grounds-differences-prac-recommenda_sk.pdf)

slovenščina (SL) (79.79 KB - PDF)

**First published:**

30/09/2014

**Last updated:**

11/05/2017

[View](/sl/documents/scientific-conclusion/imprida-h-c-775-a31-0069-epar-scientific-conclusions-grounds-variation-terms-marketing-authorisations-and-detailed-explanation-scientific-grounds-differences-prac-recommenda_sl.pdf)

Suomi (FI) (529 KB - PDF)

**First published:**

30/09/2014

**Last updated:**

11/05/2017

[View](/fi/documents/scientific-conclusion/imprida-h-c-775-a31-0069-epar-scientific-conclusions-grounds-variation-terms-marketing-authorisations-and-detailed-explanation-scientific-grounds-differences-prac-recommenda_fi.pdf)

svenska (SV) (50.18 KB - PDF)

**First published:**

30/09/2014

**Last updated:**

11/05/2017

[View](/sv/documents/scientific-conclusion/imprida-h-c-775-a31-0069-epar-scientific-conclusions-grounds-variation-terms-marketing-authorisations-and-detailed-explanation-scientific-grounds-differences-prac-recommenda_sv.pdf)

Imprida-H-C-775-A31-0069 : EPAR - Assessment Report - Article 31

Adopted

Reference Number: EMA/PRAC/294920/2014

English (EN) (977.44 KB - PDF)

**First published:** 30/09/2014

**Last updated:** 11/05/2017

[View](/en/documents/variation-report/imprida-h-c-775-a31-0069-epar-assessment-report-article-31_en.pdf)

Imprida-H-C-775-WS-0360 : EPAR - Assessment Report - Variation

Adopted

Reference Number: EMA/CHMP/356249/2013

English (EN) (899.8 KB - PDF)

**First published:** 11/12/2013

**Last updated:** 11/05/2017

[View](/en/documents/variation-report/imprida-h-c-775-ws-0360-epar-assessment-report-variation_en.pdf)

CHMP post-authorisation summary of positive opinion for Imprida

Adopted

Reference Number: EMA/CHMP/397194/2013

English (EN) (529.1 KB - PDF)

**First published:** 28/06/2013

**Last updated:** 11/05/2017

[View](/en/documents/smop/chmp-post-authorisation-summary-positive-opinion-imprida_en.pdf)

Imprida-H-C-775-WS-0100-G : EPAR - Assessment Report - Variation

Adopted

English (EN) (1.34 MB - PDF)

**First published:** 07/09/2011

**Last updated:** 11/05/2017

[View](/en/documents/variation-report/imprida-h-c-775-ws-0100-g-epar-assessment-report-variation_en.pdf)

## Initial marketing authorisation documents

Imprida : EPAR - Procedural steps taken before authorisation

English (EN) (475.09 KB - PDF)

**First published:** 21/02/2007

**Last updated:** 11/05/2017

[View](/en/documents/procedural-steps/imprida-epar-procedural-steps-taken-authorisation_en.pdf)

Imprida : EPAR - Scientific Discussion

English (EN) (949.06 KB - PDF)

**First published:** 21/02/2007

**Last updated:** 11/05/2017

[View](/en/documents/scientific-discussion/imprida-epar-scientific-discussion_en.pdf)

#### News on Imprida

[Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 24-27 June 2013](/en/news/meeting-highlights-committee-medicinal-products-human-use-chmp-24-27-june-2013) 28/06/2013

[Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 13-16 May 2013](/en/news/meeting-highlights-pharmacovigilance-risk-assessment-committee-prac-13-16-may-2013) 17/05/2013

[Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 17-20 October 2011](/en/news/meeting-highlights-committee-medicinal-products-human-use-chmp-17-20-october-2011) 21/10/2011

[European Medicines Agency concludes that benefit-risk balance of angiotensin-II-receptor antagonists remains positive](/en/news/european-medicines-agency-concludes-benefit-risk-balance-angiotensin-ii-receptor-antagonists-remains-positive) 20/10/2011

[European Medicines Agency recommendation on use of angiotensin-II-receptor antagonists during pregnancy](/en/news/european-medicines-agency-recommendation-use-angiotensin-ii-receptor-antagonists-during-pregnancy) 24/04/2008

#### More information on Imprida

Questions and answers on the review of angiotensin-II-receptor antagonists and the risk of cancer

Reference Number: EMA/CHMP/834168/2011

English (EN) (511.41 KB - PDF)

**First published:** 20/10/2011

**Last updated:** 11/05/2017

[View](/en/documents/opinion-any-scientific-matter/questions-answers-review-angiotensin-ii-receptor-antagonists-risk-cancer_en.pdf)

- [Renin-angiotensin-system (RAS)-acting agents: Article-31 referral](/en/medicines/human/referrals/renin-angiotensin-system-ras-acting-agents)

**This page was last updated on** 11/05/2017

## Share this page

[Back to top](#main-content)